Joshua D. Chandler

Joshua D. Chandler

Auto-generated profile, based on publicly available information

Joshua D. Chandler

Division of Pulmonology, Asthma, Cystic Fibrosis and Sleep, Department of Pediatrics, Emory University School of Medicine, USA

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 March 2023 in Blood Advances
Verified
Journal Article
Open access
PDF file
DEDevon J. Eddins
Devon J. Eddins
JYJunkai Yang
Junkai Yang
AKAstrid Kosters
Astrid Kosters
VGVincent Giacalone
Vincent Giacalone
XPXimo Pechuan-Jorge
Ximo Pechuan-Jorge
EGEliver E. B. Ghosn
Eliver E. B. Ghosn
Troubling disparities in COVID-19–associated mortality emerged early, with nearly 70% of deaths confined to Black/African American (AA) patients in some areas. However, targeted studies on this vulnerable population are scarce. Here, we applied multiomics single-cell analyses of immune profiles from matching airways and blood samples of Black/AA patients during acute SARS-CoV-2 infection. Transcriptional reprogramming of infiltrating IFITM2+/S100A12+ mature neutrophils, likely recruited via the IL-8/CXCR2 axis, leads to persistent and self-sustaining pulmonary neutrophilia with advanced features of acute respiratory distress syndrome (ARDS) despite low viral load in the airways. In addition, exacerbated neutrophil production of IL-8, IL-1β, IL-6, and CCL3/4, along with elevated levels of neutrophil elastase and myeloperoxidase, were the hallmarks of transcriptionally active and pathogenic airway neutrophilia. Although our analysis was limited to Black/AA patients and was not designed as a comparative study across different ethnicities, we present an unprecedented in-depth analysis of the immunopathology that leads to acute respiratory distress syndrome in a well-defined patient population disproportionally affected by severe COVID-19.

4 April 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
SDSamuel Druzak
Samuel Druzak
EIElizabeth Iffrig
Elizabeth Iffrig
Blaine RobertsBlaine Roberts
Blaine Roberts
TZTiantian Zhang
Tiantian Zhang
KFKirby S. Fibben
Kirby S. Fibben
CMCheryl L. Maier
Cheryl L. Maier
The pathogenesis of multi-organ dysfunction associated with severe acute SARS-CoV-2 infection remains poorly understood. Endothelial damage and microvascular thrombosis have been identified as drivers of COVID-19 severity, yet the mechanisms underlying these processes remain elusive. Here we show alterations in fluid shear stress-responsive pathways in critically ill COVID-19 adults as compared to non-COVID critically ill adults using a multiomics approach. Mechanistic in-vitro studies, using microvasculature-on-chip devices, reveal that plasma from critically ill COVID-19 adults induces fibrinogen-dependent red blood cell aggregation that mechanically damages the microvascular glycocalyx. This mechanism appears unique to COVID-19, as plasma from non-COVID sepsis patients demonstrates greater red blood cell membrane stiffness but induces less significant alterations in overall blood rheology. Multiomics analyses in pediatric patients with acute COVID-19 or the post-infectious multi-inflammatory syndrome in children (MIS-C) demonstrate little overlap in plasma cytokine and metabolite changes compared to adult COVID-19 patients. Instead, pediatric acute COVID-19 and MIS-C patients show alterations strongly associated with cytokine upregulation. These findings link high fibrinogen and red blood cell aggregation with endotheliopathy in adult COVID-19 patients and highlight differences in the key mediators of pathogenesis between adult and pediatric populations.

24 June 2021 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
Demba SarrDemba Sarr
Demba Sarr
AGAaron D. Gingerich
Aaron D. Gingerich
NANuha Milad Asthiwi
Nuha Milad Asthiwi
FAFaris Almutairi
Faris Almutairi
Giuseppe Andrea SauttoGiuseppe Andrea Sautto
Giuseppe Andrea Sautto
BRBalazs Rada
Balazs Rada
Significance: Influenza infections kill millions of people worldwide. Current prophylactic treatment options are limited due to viral strain–specific vaccinations and emerging drug resistance. It is important to discover new immune mechanisms that can fight the influenza virus. Our work presented here identifies such a mechanism. The Duox1 protein helps the airways to clear influenza virus and to reduce infection-related death and sickness in an animal model. Duox1 delays the infection process by directly targeting the virus. Unlike current vaccines, this mechanism is effective against several influenza strains. Our study identifies the function of theDuox1gene and suggests that it has a therapeutic potential against influenza and potentially other respiratory pathogens, worth exploring in the future.

9 September 2022 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Closed access
KCKirsten A. Cottrill
Kirsten A. Cottrill
SSSusan T. Stephenson
Susan T. Stephenson
AMAhmad F. Mohammad
Ahmad F. Mohammad
SKSusan O. Kim
Susan O. Kim
NMNael A. McCarty
Nael A. McCarty
JCJoshua D. Chandler
Joshua D. Chandler

25 May 2023 in Journal of Cystic Fibrosis
Verified
Journal Article
Closed access
JCJonathan Yuxuan Chen
Jonathan Yuxuan Chen
SLSong Li
Song Li
GSGeorge L. Silva
George L. Silva
JCJoshua D. Chandler
Joshua D. Chandler
MPMark R. Prausnitz
Mark R. Prausnitz
LGLokesh Guglani
Lokesh Guglani

23 January 2025 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
AAAshley Avila
Ashley Avila
ALAva S. Lewandowski
Ava S. Lewandowski
YLYongjun Li
Yongjun Li
JGJesse Gui
Jesse Gui
KLKaeun A. Lee
Kaeun A. Lee
SZShirley L. Zhang
Shirley L. Zhang
To regulate brain function, peripheral compounds must traverse the blood–brain barrier (BBB), an interface between the brain and the circulatory system. To determine whether specific transport mechanisms are relevant for sleep, we conducted a BBB-specific inducible RNAi knockdown (iKD) screen for genes affecting sleep in Drosophila . We observed reduced sleep with knockdown of solute carrier CG6126 , a carnitine transporter, as determined by isotope flux. Our findings suggest that CG6126 regulation of sleep is through the role of the carnitine shuttle in regulating fatty acid metabolism as lipid droplets accumulate in the brains of CG6126 BBB iKD flies. Knocking down mitochondrial carnitine transferases in non-BBB glial cells mimicked the reduced sleep of the CG6126 BBB iKD flies, while bypassing the necessity of carnitine transport with dietary medium-chain fatty acids or palmitoylcarnitine rescued sleep. We propose that carnitine transport via CG6126 promotes brain fatty acid metabolism necessary for maintaining sleep.